Tokyo, Oct. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058965) titled 'Auditory steady state responses in hearing loss' on Oct. 1.
Study Type:
Observational
Primary Sponsor:
Institute - International University of Health and Welfare
Condition:
Condition - hearingloss
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Auditory temporal resolution, as well as hearing threshold, plays an important role in speech recognition. Objective measurement of changes in brain activity related to auditory temporal resolution in patients with hearing loss using electroencephalography.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
=
Gender - Male and Female
Key inclusion criteria - Patients with hearing loss
Key exclusion criteria - History of psychiatric or neurological disease, cardiac pacemaker, neuro pacemaker, previous head surgery, pregnant, wearing orthodontic appliances
Target Size - 20
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 09 Month 02 Day
Anticipated trial start date - 2025 Year 09 Month 30 Day
Last follow-up date - 2029 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067432
Disclaimer: Curated by HT Syndication.
